Related Experiment Video
Updated: May 4, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
The impact of MITF on melanoma development: news from bench and bedside
Elisabeth M Roider1, David E Fisher1
1Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Abstract:
In the current issue, two articles highlight the impact of melanocyte transcription factor (MITF) on melanoma development. In the first, Lister et al. reveal in vivo proof of MITF directly regulating tumor development in BRAF(V600E) melanomas. In the second, Sturm et al. present a clinical trial that emphasizes the importance of the recently discovered E318K MITF germline mutation in patients with multiple primary melanomas.
Related Concept Videos
Mitogens and the Cell Cycle
Tumor Immunotherapy
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

